These data indicate targeting DNM2 transcription significantly suppresses proliferation of ALL cells and that inhibiting DNM2 with TBB, a CK2–inhibitor restores Ikaros function. The gene discussed is DNM2; the disease is acute lymphoblastic leukemia.